Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial papaverine for severe post-SAH cerebral vasospasm
2010-023878-40Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of papaverine in cerebral vasospasm and subarachnoid hemorrhage (SAH), sponsored by Medical University of Vienna. Primary endpoint: Increase in cerebral glucose concentrations. Started Dec 2011; status: completed.
02
Drugs
papaverine
03
Conditions
cerebral vasospasmsubarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2010-023878-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023878-40.